<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1381</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2002</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>PRODUCTIO N OF PROSTATE-SPECIFIC ANTIGEN (PSA) BY A BREAST CANCER CELL LINE, SK-Br-3</title>
	<subject_fa>Immunology</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>Original Research: Basic Science in Medicine</content_type_fa>
	<content_type>Original Research: Basic Science in Medicine</content_type>
	<abstract_fa></abstract_fa>
	<abstract>PSA is a 33-KDa serine protease that is produced predominantly by prostate
epithelium. However, it has been shown that about 30-40% of female breast tumors
produce PSA and its production is associated with the presence of estrogen
and progesterone receptors. We have now developed a new tissue culture system
to study PSA production in breast cancer and its association with prognostic factors
such as progesterone receptor and c-erbB-2. For this purpose we investigated
the ability of PSA production in five different cell lines, including two breast
cancer cell lines, SK-Br-3 and MDA-MB-453. The PSA in tissue culture supernatant
and cytoplasm of the Sk-Br-3 cell line was detected by western blotting
and immunoperoxidase, respectively. Furthermore, we found lower expression of
c-erbB-2 in Sk-Br-3 than non-PSA producer breast cancer cell line, MDA-MB-
453. Progesterone receptor was expressed by both PSA-positive and -negative
cell lines and only the intensity of staining and the number of positive cells in SkBr-
3 population was higher than MDA-MB-453. According to our findings PSA
can be considered as a good prognostic factor in breast cancer and we suggest that
these two cell lines are a good in vitro model to study the relationship of different
breast cancer prognostic factors and their regulations.
Keywords: PSA, c-erbB-2, Progesterone receptor, Breast cancer, SK-Br-3.

</abstract>
	<keyword_fa></keyword_fa>
	<keyword>PSA, c-erbB-2, Progesterone receptor, Breast cancer, SK-Br-3.</keyword>
	<start_page>41</start_page>
	<end_page>46</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-230&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>E</first_name>
	<middle_name></middle_name>
	<last_name>KAMALI SARVESTANI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>immunol 2@sums.ac.ir</email>
	<code>20031947532846004078</code>
	<orcid>20031947532846004078</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Department of Immunology,Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A</first_name>
	<middle_name></middle_name>
	<last_name>GHADERI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004079</code>
	<orcid>20031947532846004079</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>B</first_name>
	<middle_name></middle_name>
	<last_name>GHARESI-FARD</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004080</code>
	<orcid>20031947532846004080</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
